Free Trial
LON:ROQ

Roquefort Therapeutics (ROQ) Share Price, News & Analysis

Roquefort Therapeutics logo
GBX 1.57 +0.02 (+1.29%)
As of 07:33 AM Eastern

About Roquefort Therapeutics Stock (LON:ROQ)

Key Stats

Today's Range
1.55
1.57
50-Day Range
1.33
2
52-Week Range
1.08
6.78
Volume
12,031 shs
Average Volume
2.11 million shs
Market Capitalization
£2.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ROQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ROQ Stock News Headlines

The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.
Roquefort Thera Share Chat (ROQ)
See More Headlines

ROQ Stock Analysis - Frequently Asked Questions

Roquefort Therapeutics' stock was trading at GBX 4.10 on January 1st, 2025. Since then, ROQ shares have decreased by 61.7% and is now trading at GBX 1.57.

Roquefort Therapeutics plc (LON:ROQ) released its quarterly earnings results on Wednesday, April, 30th. The company reported ($0.75) earnings per share (EPS) for the quarter. Roquefort Therapeutics had a negative net margin of 57,057.07% and a negative trailing twelve-month return on equity of 29.57%.

Shares of ROQ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Roquefort Therapeutics investors own include Vislink Technologies (XGTI), AutoZone (AZO), Intel (INTC), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), TJX Companies (TJX) and Abacus Health Products (ABAHF).

Company Calendar

Last Earnings
4/30/2025
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:ROQ
CIK
N/A
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£1.52 million
Net Margins
-57,057.07%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£2.66 thousand
Cash Flow
GBX 0.96 per share
Price / Cash Flow
1.49
Book Value
GBX 3.82 per share
Price / Book
0.37

Miscellaneous

Free Float
N/A
Market Cap
£1.82 million
Optionable
Not Optionable
Beta
0.05
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (LON:ROQ) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners